UltraSight
Edit

UltraSight

http://www.ultrasight.com/
Last activity: 25.08.2026
Active
Categories: Artificial IntelligenceCareEdTechHardwareHealthTechLearnMedTechPlatformProviderTraining
OnSight Medical aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The OnSight automated guidance system and advanced usability features help bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere.
Followers
249
Followers
295
Mentions
28
Location: Israel, Central, Rehovot
Employees: 11-50
Total raised: $13M
Founded date: 2018

Investors 2

Funding Rounds 1

DateSeriesAmountInvestors
21.05.2021Series B$13M-

Mentions in press and media 28

DateTitleDescription
13.07.2026Novice Users Acquire Diagnostic-Quality Cardiac Ultrasound Images With AI Guidance, Peer-Reviewed Study FindsProspective study evaluated AI-guided image acquisition with handheld ultrasound BOSTON, MA, UNITED STATES, July 13, 2026 /EINPresswire.com/ -- UltraSight™, a leader in AI-guided cardiac imaging, today announced new clinical data from a pro...
05.06.2026UltraSight™ to Participate in Mayo Clinic Innovation Summit Focused on the Future of Cardiovascular CareCEO Davidi Vortman to join healthcare leaders discussing the future of cardiovascular collaboration and care delivery BOSTON, MA, UNITED STATES, June 4, 2026 /EINPresswire.com/ -- UltraSight™, a leader in AI-guided cardiac imaging, today an...
03.06.2026UltraSight™ Selected for MedTech Innovator’s 2026 Accelerator Cohort and Inaugural MTI IndexCompany, among the top 4% of global applicants, selected to the world’s largest accelerator for medical technology startups BOSTON, MA, UNITED STATES, June 3, 2026 /EINPresswire.com/ -- UltraSight™, a leader in AI-guided cardiac imaging, to...
29.05.2026MedTech Innovator: 65 Startups Selected For 2026 Accelerator Cohort, Launches MTI IndexMedTech Innovator (MTI), the world’s largest accelerator for medical technology startups, announced the 65 companies selected for its 2026 Accelerator Cohort and unveiled the MTI Index, a new recognition platform designed to provide investo...
26.05.2026UltraSight™ Study Shows Novices Achieve Diagnostic-Quality Cardiac Ultrasound After One Day of AI-Guided TrainingPublished in European Heart Journal – Digital Health, multicenter findings showed novices achieved diagnostic-quality cardiac ultrasound in 97.7% of cases BOSTON, MA, UNITED STATES, May 26, 2026 /EINPresswire.com/ -- UltraSight™, a leader i...
19.05.2026UltraSight™ Appoints Rick Geoffrion as Chairman of the BoardLeadership appointment supports continued expansion of AI-guided cardiac ultrasound across hospitals, health systems, and strategic partnerships BOSTON, MA, UNITED STATES, May 19, 2026 /EINPresswire.com/ -- UltraSight™, a leader in AI-guide...
16.04.2026ARC Launches ‘ARC Landing Boston’ Healthtech Accelerator with Massachusetts Governor Maura Healeyphoto credit: Nicole Loeb, Brightside Media What You Should Know The Launch: ARC (the innovation arm of Israel’s Sheba Medical Center) has officially launched ARC Landing Boston in partnership with the administration of Massachusetts Govern...
18.03.2026New Data at ACC.26 Demonstrating UltraSight™ AI Enables Non-Experts to Perform Diagnostic Cardiac UltrasoundSix studies in collaboration with Mayo Clinic confirm the UltraSight™ Echosystem enables non-expert clinicians to deliver diagnostic-quality cardiac ultrasound BOSTON, MA, UNITED STATES, March 18, 2026 /EINPresswire.com/ -- UltraSight™, a l...
04.03.2026UltraSight™ PVAD IQ Facilitates Expert-Level Microaxial Flow Pump Assessment, Late-Breaking Data at 2026 THT ConferenceBOSTON, MA, UNITED STATES, March 4, 2026 /EINPresswire.com/ -- UltraSight™, a leader in AI-guided cardiac imaging workflows, today announced Late-Breaking clinical study results about its PVAD IQ at the 2026 Technology and Heart Failure The...
25.02.2026UltraSight™ Advances AI-Enabled Workflows in Cardiac Critical CareBOSTON, MA, UNITED STATES, February 25, 2026 /EINPresswire.com/ -- UltraSight™, a leader in AI-guided cardiac imaging workflows, today announced U.S. Food and Drug Administration (FDA) clearance of PVAD IQ, an imaging tool used with the com...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In